Overall administration, clinical operations support and concept and protocol development, implementation and assays
Ended Awarded Last action
- Contract number
- HHSN27200013
- Awardee
-
University Of Maryland, Baltimore UEI Z9CRZKD42ZT1 Part of University System Of Maryland
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,492,835
Award facts
- Opportunity
-
- FY2017A1B1C1D10048 Solicitation number
- Contract value 100% obligated
- $1,492,834.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 9 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Baltimore, MD 21201, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$77,278 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $515,716 | |
| Other Administrative Action | $0 | |
| Change Order | $317,617 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $208,465 | |
| Exercise an Option | $158,865 | |
| Original award | $369,450 |
Show all 11
About this award
This is a delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to the University of Maryland, Baltimore (UMB) for overall administration, clinical operations support, and concept and protocol development, implementation and assays related to the Vaccine and Treatment Evaluation Units (VTEU) program. The contract has a ceiling value of $1,492,834.57 and runs from July 18, 2016 to July 14, 2021. This delivery order is part of a larger VTEU master IDIQ contract. The contract does not have a set-aside designation. UMB has subcontracted portions of the work to the University of California, Irvine and Icahn School of Medicine at Mount Sinai to develop a supplemental protein microarray for analyzing human serum against influenza.
Quick answers
Who was awarded contract HHSN27200013?
HHSN27200013 was awarded to University Of Maryland, Baltimore by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 18, 2016.
How much is contract HHSN27200013 worth?
The government has obligated $1,492,835 on HHSN27200013.
Is contract HHSN27200013 an order under another contract?
Yes. HHSN27200013 is a delivery order under HHSN272201300022I, an indefinite delivery contract, on Vaccine and Treatment Evaluation Units (VTEU).
Was contract HHSN27200013 competed?
The extent of competition for HHSN27200013 was full and open competition. The government received 9 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award